OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role and mechanisms of gut microbiota in diabetic nephropathy, diabetic retinopathy and cardiovascular diseases
Qiulan Lv, Zhiyuan Li, Aihua Sui, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 22

Showing 22 citing articles:

Current knowledge of bone-derived factor osteocalcin: its role in the management and treatment of diabetes mellitus, osteoporosis, osteopetrosis and inflammatory joint diseases
Monika Martiniaková, Roman Bíro, Veronika Kováčová, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 4, pp. 435-452
Open Access | Times Cited: 20

The roles of gut microbiota and its metabolites in diabetic nephropathy
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 23

A trend of osteocalcin in diabetes mellitus research: bibliometric and visualization analysis
Terry Z. Liu, Yuchen Mao, Kangping Yang, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access

Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota
Xiaqing Wu, Lei Zhao, Yanlong Zhao, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 423-435
Open Access | Times Cited: 6

Alterations of the gut microbiota in patients with diabetic nephropathy and its association with the renin-angiotensin system
Fatemeh Zali, Abdorrahim Absalan, Golnaz Bahramali, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access

The role and mechanism of the gut microbiota in the development and treatment of diabetic kidney disease
Xiaofang Wu, Lei Zhao, Yújiāng Zhāng, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 13

Large-scale causal analysis of gut microbiota and six common complications of diabetes: a mendelian randomization study
Jiachen Wang, Menghao Teng, Ruoyang Feng, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4

Yi-Shen-Hua-Shi regulates intestinal microbiota dysbiosis and protects against proteinuria in patients with chronic kidney disease: a randomized controlled study
Xingtong Dong, Jialing Zhang, Wen Li, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 356-366
Open Access | Times Cited: 4

Gut Microbiota Dysbiosis in Diabetic Retinopathy—Current Knowledge and Future Therapeutic Targets
Dragoș Șerban, Ana Maria Dascălu, Andreea Letiția Arsene, et al.
Life (2023) Vol. 13, Iss. 4, pp. 968-968
Open Access | Times Cited: 10

Underlying mechanisms of traditional Chinese medicine in the prevention and treatment of diabetic retinopathy: evidences from molecular and clinical studies
Zhengpin Li, Faquan Hu, Liyuan Xiong, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118641-118641
Closed Access | Times Cited: 3

Causal relationship of gut microbiota with diabetic nephropathy: a Mendelian randomization analysis
Wei Yan, Ying Ge, Lina Wang, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 2

Integrated 16S rRNA sequencing and metabolomic analysis reveals the potential protective mechanism of Germacrone on diabetic nephropathy in mice
Yunguang Wang, Xinxin He, Mengjiao Xue, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 2

Assessing the causal relationship between gut microbiota and diabetic nephropathy: insights from two-sample Mendelian randomization
Yipeng Fang, Yunfei Zhang, Qian Liu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2

Causal relationship between T2DM microvascular complications and gut microbiota: a Mendelian randomization study
Junping Zhang, Zilu Yu, Shanshan Li, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2

Review of the pharmacological properties of marine macroalgae used in the treatment of diabetes mellitus in Indonesia
Agung Giri Samudra, Agung Endro Nugroho, Retno Murwanti
Annales Pharmaceutiques Françaises (2024)
Closed Access | Times Cited: 1

Pathogenesis and management of diabetic gastroparesis: An updated clinically oriented review
Srikar Uppaluri, Manisha Jain, Hira Ali, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 3, pp. 102994-102994
Closed Access | Times Cited: 1

Gut microbiota microbial metabolites in diabetic nephropathy patients: far to go
Jianxiu Yu, Xin Chen, Su-Gang Zang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1

Molecular Therapeutics for Diabetic Kidney Disease: An Update
Man Guo, Fang-Fang He, Chun Zhang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10051-10051
Open Access | Times Cited: 1

Association between gut microbiota and diabetic nephropathy: a two-sample mendelian randomization study
Shisheng Han, Yinqing Chen, Yan Lu, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access

Page 1

Scroll to top